Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C73305
http://purl.obolibrary.org/obo/NCIT_C73305
|
|---|---|
| Preferred Name | Belotecan |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | Belotecan
|
|---|---|
| label | Belotecan
|
| Has_Salt_Form | |
| code | C73305
|
| prefixIRI | NCIT:C73305
|
| in_subset | |
| Preferred_Name | Belotecan
|
| FDA_UNII_Code | 27Z82M2G1N
|
| Contributing_Source | FDA
|
| Chemical_Formula | C25H27N3O4
|
| CAS_Registry | 256411-32-2
|
| Legacy Concept Name | Belotecan
|
| type | |
| ALT_DEFINITION | The active ingredient in a substance being studied in the treatment of small cell lung cancer and other types of cancer. It blocks certain enzymes needed for cell division and DNA repair, and it may kill cancer cells. It is a type of camptothecin analog and a type of topoisomerase inhibitor.
|
| subClassOf | |
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C0762737
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |